<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05100290</url>
  </required_header>
  <id_info>
    <org_study_id>B076201836758-1</org_study_id>
    <nct_id>NCT05100290</nct_id>
  </id_info>
  <brief_title>Predictive Properties of the Hyperventilation Provocation Test for the Diagnosis of the Hyperventilation Syndrome</brief_title>
  <official_title>Predictive Properties of the Hyperventilation Provocation Test for the Diagnosis of the Hyperventilation Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Saint Pierre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Université Libre de Bruxelles</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hopitaux Iris Sud</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire Saint Pierre</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Hyperventilation Provocation Test (HPTest) associated with end-tidal CO2 pressure&#xD;
      (PETCO2) measurement is a diagnostic tool for idiopathic hyperventilation syndrome (HVS).&#xD;
      However, interpretation of HPTest remains unclear regarding the relevant PETCO2 values to&#xD;
      consider and the occurrence of subjective symptoms.&#xD;
&#xD;
      This case-control study aims to identify accurate HPTest measurements for the diagnosis of&#xD;
      HVS, regardless of symptoms occurrence.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will analyze in a retrospective way HPTest datas from 74 subjects,&#xD;
      involving 37 subjects with complaints and a Nijmegen questionnaire score of ≥23/64 (HVS+)&#xD;
      matched on gender, age, height, weight and BMI category with 37 healthy controls without&#xD;
      complaints and a Nijmegen questionnaire score of &lt;23/64 (HVS-)(16).&#xD;
&#xD;
      To rule out confounding respiratory pathology, each participant will have completed&#xD;
      spirometry and methacholine testing, that will have a result within expected normal values.&#xD;
&#xD;
      All data will have to be collected by the same equipment and by the same operators in the&#xD;
      pulmonology department of the CHU-St Pierre-Brussels between September 2015 and December&#xD;
      2020.&#xD;
&#xD;
      Kinetics of the PETCO2 recorded during each of the 3 phases of the HPTest (adaptation,&#xD;
      hyperventilation and recovery) will be mathematically modeled by an curvilinear model with&#xD;
      the parameters (A, A', a and a') noted from the kinetic equation (TAU) : TAU&#xD;
      [PETCO2(t)〖=A+a(1-exp〗^((b-t)/c))]. For any observed differences in parameters between&#xD;
      groups, the Area Under Curves will be estimated at the cut-off that offers the best&#xD;
      Sensitivity and Specificity.&#xD;
&#xD;
      The probability of a type I error is set at 5%.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 15, 2021</start_date>
  <completion_date type="Actual">October 15, 2021</completion_date>
  <primary_completion_date type="Actual">October 15, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>PetCO2 recovery (5min)</measure>
    <time_frame>5 minute of recovery</time_frame>
    <description>PetCO2 at the end (5th minute) of the recovery phase of the HPTest</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PetCO2 recovery (3min)</measure>
    <time_frame>3 minute of recovery</time_frame>
    <description>PetCO2 at the end (3d minute) of the recovery phase of the HPTest</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">74</enrollment>
  <condition>Hyperventilation Syndrome</condition>
  <arm_group>
    <arm_group_label>HVS+</arm_group_label>
    <description>Subjects without documented respiratory or cardiac disease, with a spirometry and metacholine tests within expected values AND with complaints documented by a Nijmegen questionnaire score of ≥23/64 (suspected of idiopathic hyperventilation)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HVS-</arm_group_label>
    <description>Healthy controls without documented respiratory or cardiac disease, with a spirometry and metacholine tests within expected values AND without complaints documented by a Nijmegen questionnaire score of &lt;23/64</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Hyperventilation Provocation Test (HPTest)</intervention_name>
    <description>During the HPTest, the subject is comfortably seated in a chair with armrests and breathes in a mouthpiece with a salivary collector and a nasal clamp. Parameters of ventilation and gas exchange are analyzed via an Oxycon ProTM (SN808008) with TripleV-Volume Sensor digital(Jaeger).&#xD;
The HPTest begins with a 3-minutes adaptation phase during which the patient is asked to &quot;breathe normally&quot;. During the 3-minutes of voluntary hyperventilation phase, the patient is asked to increase his tidal volume and support a breath rate of at least 30/min in order to reduce his PETCO2 by at least 50%. During the recovery phase of the HPTest, the patient is invited to regain a &quot;natural breathing&quot; for 5 minutes, without guidance on tidal volume or breath rate.</description>
    <arm_group_label>HVS+</arm_group_label>
    <arm_group_label>HVS-</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who visited the pulmonary department and performed a HPTest on medical&#xD;
        prescription&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Anyone over 18 years of age who has completed an HPTest and a Nijmegen questionnaire&#xD;
             between 2015 and 2020&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vincent Ninane</last_name>
    <role>Study Director</role>
    <affiliation>CHU St PIerre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU St Pierre</name>
      <address>
        <city>Brussels</city>
        <state>Brabant</state>
        <zip>1000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 18, 2021</study_first_submitted>
  <study_first_submitted_qc>October 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2021</study_first_posted>
  <last_update_submitted>November 2, 2021</last_update_submitted>
  <last_update_submitted_qc>November 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperventilation</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

